GlassScriptPhysician profile
Maria T Rizzo
NPI 1689825929
$3,515.44
in general payments reported to CMS, 2019-2025
34 companies · $210 in 2025
The $210 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $119 · 2022: $836 · 2023: $1,048 · 2024: $1,303 · 2025: $210.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,561.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,560.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $399.24 | 2022-2024 | |
| Janssen Biotech, INC. | $367.83 | 2022-2024 | Simponi Aria, Tremfya, Simponi |
| Janssen Pharmaceuticals, INC | $255.19 | 2022-2024 | Invega Sustenna, Spravato |
| Otsuka America Pharmaceutical, INC. | $225.55 | 2024 | Rexulti |
| Bausch Health US, LLC | $223.99 | 2022-2024 | Aplenzin, Wellbutrin |
| Alkermes, INC. | $218.08 | 2022-2024 | Aristada, Lybalvi |
| Teva Pharmaceuticals USA, INC. | $196.51 | 2023-2025 | Austedo Xr, Uzedy, Austedo |
| Amgen INC. | $169.70 | 2021-2024 | Tavneos, Enbrel, Otezla |
| Ucb, INC. | $167.47 | 2022-2024 | Cimzia |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $147.49 | 2022-2024 | Caplyta |
| Axsome Therapeutics, INC. | $140.00 | 2023-2024 | Auvelity, Sunosi |
| Indivior INC. | $119.66 | 2023-2024 | Sublocade |
| Neurocrine Biosciences, INC. | $102.17 | 2022-2025 | Ingrezza |
| Takeda Pharmaceuticals U.S.A., INC. | $90.86 | 2022-2024 | Trintellix |
| Idorsia Pharmaceuticals US INC | $86.98 | 2023-2024 | Quviviq |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $82.21 | 2021-2025 | |
| Merz Pharmaceuticals, LLC | $65.64 | 2025 | Inbrija, Xeomin |
| Glaxosmithkline, LLC. | $61.71 | 2021-2022 | |
| Vanda Pharmaceuticals INC. | $58.47 | 2024 | Fanapt |
| Lundbeck LLC | $42.64 | 2024-2025 | Rexulti |
| Livanova USA, INC. | $39.56 | 2024 | Vns Therapy Symmetry Model 8103 Generator |
| Eisai INC. | $28.27 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $24.35 | 2023 | Zilretta |
| Catalyst Pharmaceuticals, INC. | $22.80 | 2024 | |
| Biogen, INC. | $22.08 | 2025 | Skyclarys |
| Sandoz INC. | $21.12 | 2023 | Hyrimoz |
| Actelion Pharmaceuticals US, INC. | $20.38 | 2024 | Uptravi, Opsumit |
| Fidia Pharma USA INC. | $19.62 | 2024 | Triluron, Hymovis, Hyalgan |
| Aurinia Pharma U.S., INC. | $18.61 | 2022 | |
| Almatica Pharma LLC | $17.53 | 2024 | Teriparatide, Loreev Xr |
| E.R. Squibb & Sons, L.L.C. | $16.95 | 2024 | |
| Ultragenyx Pharmaceutical INC. | $15.37 | 2021 | |
| Lilly USA, LLC | $14.47 | 2021 | |
| Orexo US, INC. | $12.94 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maria Rizzo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.